These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 15852198
1. Vaginal hormone therapy for urogenital and menopausal symptoms. Ballagh SA. Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198 [Abstract] [Full Text] [Related]
2. The effects of hormones on urinary incontinence in postmenopausal women. Quinn SD, Domoney C. Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Archer DF. Menopause; 2010 Apr; 17(1):194-203. PubMed ID: 19602990 [Abstract] [Full Text] [Related]
4. Medical and surgical strategies for treating urogynecological disorders. Samsioe G. Int J Fertil Menopausal Stud; 1996 Apr; 41(2):136-41. PubMed ID: 8829692 [Abstract] [Full Text] [Related]
5. The postmenopausal bladder. Hillard T. Menopause Int; 2010 Jun; 16(2):74-80. PubMed ID: 20729499 [Abstract] [Full Text] [Related]
6. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Smith P. Acta Obstet Gynecol Scand Suppl; 1993 Jun; 157():1-26. PubMed ID: 8393609 [Abstract] [Full Text] [Related]
7. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy. Santos I, Clissold S. Gynecol Endocrinol; 2010 Sep; 26(9):644-51. PubMed ID: 20374067 [Abstract] [Full Text] [Related]
9. Options for hormone therapy in women who have had a hysterectomy. Haney AF, Wild RA. Menopause; 2007 Nov 15; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150 [Abstract] [Full Text] [Related]
10. [Topical hormonal treatment and urogenital atrophy]. Sitruk-Ware R, Thomas JL. Praxis (Bern 1994); 1997 Aug 13; 86(33):1245-8. PubMed ID: 9381009 [Abstract] [Full Text] [Related]
13. Estriol: safety and efficacy. Head KA. Altern Med Rev; 1998 Apr 13; 3(2):101-13. PubMed ID: 9577246 [Abstract] [Full Text] [Related]
14. Genitourinary symptoms in the menopausal transition. Van Voorhis BJ. Am J Med; 2005 Dec 19; 118 Suppl 12B():47-53. PubMed ID: 16414326 [Abstract] [Full Text] [Related]
15. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Obstet Gynecol; 2008 Jan 19; 111(1):67-76. PubMed ID: 18165394 [Abstract] [Full Text] [Related]
16. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Menopause; 2008 Jan 19; 15(1):51-8. PubMed ID: 18257142 [Abstract] [Full Text] [Related]
17. [Urogenital complaints: value of systemic estrogen therapy]. Hänggi W, Dörflinger A. Praxis (Bern 1994); 1997 Aug 13; 86(33):1260-3. PubMed ID: 9381012 [Abstract] [Full Text] [Related]
18. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS. Climacteric; 2005 Mar 13; 8(1):83-92. PubMed ID: 15804736 [Abstract] [Full Text] [Related]
19. Estrogen and its effect on vaginal atrophy in post-menopausal women. Kelley C. Urol Nurs; 2007 Feb 13; 27(1):40-5. PubMed ID: 17390926 [Abstract] [Full Text] [Related]
20. Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction. Smith AL, Wein AJ. Discov Med; 2010 Dec 13; 10(55):500-10. PubMed ID: 21189221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]